CLINICAL VARIABLES FOR PREDICTING METASTATIC RENAL CELL CARCINOMA PATIENTS WHO WILL NOT BENEFIT FROM CYTOREDUCTIVE NEPHRECTOMY

被引：0
|
作者：
Ohno, Yoshio
Nakashima, Jun
Ohori, Makoto
Hashimoto, Takeshi
Gondo, Tatsuo
Okubo, Hideki
Shimodaira, Kenji
Tachibana, Masaaki
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.2161
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1999
引用
收藏
页码：E806 / E807
页数：3
相关论文
共 50 条
  • [21] Cytoreductive nephrectomy in metastatic renal cell carcinoma (Review)
    Dahm, Philipp
    Ergun, Onuralp
    Uhlig, Annemarie
    Bellut, Laura
    Risk, Michael C.
    Lyon, Jennifer A.
    Kunath, Frank
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (06):
  • [22] Sunitinib and Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Bajic, Petar
    Flanigan, Robert C.
    Joyce, Cara J.
    Clark, Joseph I.
    JOURNAL OF UROLOGY, 2019, 201 (03): : 453 - 454
  • [23] Partial cytoreductive nephrectomy versus cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Vitruk, Iurly
    Stakhovskyi, Oleksandr
    Voylenko, Oleg
    Kotov, Volodymyr
    Pikul, Maxim
    Stakhovsky, Eduard
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma
    Palumbo, Carlotta
    Mistretta, Francesco A.
    Knipper, Sophie
    Pecoraro, Angela
    Tian, Zhe
    Dzyuba-Negrean, Cristina
    Shariat, Shahrokh F.
    Saad, Fred
    Simeone, Claudio
    Berruti, Alfredo
    Briganti, Alberto
    Kapoor, Anil
    Antonelli, Alessandro
    Karakiewicz, Pierre I.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : E730 - E738
  • [25] FACTORS ASSOCIATED WITH CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN QUEENSLAND
    Joshi, Andre
    Wood, Simon
    Bolton, Damien
    Neale, Rachel
    Coory, Michael
    Jordan, Susan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 47 - 47
  • [26] The Effect of Cytoreductive Partial Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma
    Chen, Jiabi
    He, Qingliu
    Liu, Weihui
    Li, Yining
    Zhuang, Wei
    CLINICAL INTERVENTIONS IN AGING, 2020, 15 : 431 - 439
  • [27] Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma
    Bhindi, Bimal
    Graham, Jeffrey
    Wells, J. Connor
    Bakouny, Ziad
    Donskov, Frede
    Fraccon, Anna
    Pasini, Felice
    Lee, Jae Lyun
    Basappa, Naveen S.
    Hansen, Aaron
    Kollmannsberger, Christian K.
    Kanesvaran, Ravindran
    Yuasa, Takeshi
    Ernst, D. Scott
    Srinivas, Sandy
    Rini, Brian, I
    Bowman, Isaac
    Pal, Sumanta K.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN UROLOGY, 2020, 78 (04) : 615 - 623
  • [28] SARCOPENIA AS A PROGNOSTIC BIOMARKER OF METASTATIC RENAL CELL CARCINOMA: ITS EFFECT ON SURVIVAL BENEFIT FROM CYTOREDUCTIVE NEPHRECTOMY
    Fukushima, Hiroshi
    Koga, Fumitaka
    Nakanishi, Yasukazu
    Tobisu, Kenichi
    JOURNAL OF UROLOGY, 2015, 193 (04): : E123 - E123
  • [29] Can neutrophil-to-lymphocyte ratio be used to identify patients with metastatic renal cell carcinoma who may gain greater benefit from cytoreductive nephrectomy?
    Dai, Daphne
    Kanjanapan, Yada
    Kwan, Edmond Michael
    Yip, Desmond
    Lawrentschuk, Nathan
    Davis, Ian D.
    Azad, Arun
    Rosenthal, Mark
    Ul Arifeen, Shams
    Alam, Mahmood
    Gibbs, Peter
    Tran, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [30] Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and when
    Bex, Axel
    Powles, Tom
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (06) : 787 - 797
12345